Nimbus Therapeutics Appoints Nathalie Franchimont, M.D., Ph.D., as Chief Medical Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics, a clinical-stage company that designs and develops breakthrough medicines through its powerful computational drug discovery engine, today announced the appointment of Nathalie Franchimont, M.D., Ph.D., as Chief Medical Officer. “I am delighted to welcome Nathalie to our leadership team as Nimbus advances multiple potential breakthrough candidates into their next phase of … [Read more…]

New Analysis of UPLIZNA® (inebilizumab-cdon) Phase 3 Trial Data Demonstrates Importance of Reducing Plasmablasts to Help Prevent Neuromyelitis Optica Spectrum Disorder (NMOSD) Attacks

— Separate analysis also being presented at ECTRIMS 2022 reinforces the efficacy of UPLIZNA in patients with genetic variations — DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data from two analyses of the UPLIZNA Phase 3 pivotal trial being presented at the 38th Congress of the European Committee for Treatment and Research in … [Read more…]

CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients

BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that CareDx is hosting a webinar with the National Kidney Foundation and Honor the Gift Coalition to help patients navigate Medicare enrollment associated with … [Read more…]

Multi-omics Startup Pleno Inc. Expands Leadership Team to Accelerate Development of its Novel Hypercoding Technology

Industry Veterans and Broadcom Alumni Bring Deep Experience in Coding Theory, Software Architecture and Systems Engineering to Pleno’s Rapidly Growing Team SAN DIEGO–(BUSINESS WIRE)–#biotech—Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, announced that Jason Trachewsky has joined the company as Vice President of Software, and Professor … [Read more…]

Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors

–Accomplished neurologist and recognized industry leader brings deep scientific and clinical experience to Expansion board BOSTON–(BUSINESS WIRE)–Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the appointment of Raymond J. Kelleher, M.D., Ph.D., to its Board of Directors representing Cormorant Asset Management. Dr. Kelleher is an … [Read more…]

IQVIA Reports Third-Quarter 2022 Results

Revenue of $3,562 million grew 5.0 percent year-over-year on a reported basis and 10.5 percent at constant currency GAAP Net Income of $283 million grew 8.4 percent year-over-year Adjusted EBITDA of $814 million increased 11.8 percent year-over-year GAAP Diluted Earnings per Share of $1.49 grew 11.2 percent year-over-year Adjusted Diluted Earnings per Share of $2.48 … [Read more…]

Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced an inducement grant for Michael Amoroso, President and Chief Executive Officer of Precision BioSciences (the “Company”) under the Company’s 2021 Employment Inducement Incentive Award Plan. The inducement … [Read more…]

United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2022 financial results before the market opens on Wednesday, November 2, 2022. United Therapeutics will host a public webcast Wednesday, November 2, 2022, at 9:00 a.m. Eastern Time. The webcast will be accessible … [Read more…]

2022 CFO Survey: Most Hospital Finance Teams Still Waiting for Access to Real-Time Data

OTTAWA, Ontario–(BUSINESS WIRE)–#accounting–In August 2022, more than 100 healthcare financial professionals throughout the United States participated in a survey conducted by Becker’s Healthcare and sponsored by Multiview Financial. The survey explored the role of data analysis in hospitals and health systems. One of the most significant findings was that 90 percent of respondents reported that … [Read more…]

SmartBear Advances People and Culture with Global Leadership Hires and Office Expansions

SmartBear expands offices in Somerville, Massachusetts and Bath, England while naming new VP, Global Talent Acquisition & Culture as well as Head of ESG & Diversity SOMERVILLE, Mass. & BATH, England–(BUSINESS WIRE)–#AI—SmartBear, a leading provider of software development and visibility tools, has hired Nikki Morcom as the new VP, Global Talent Acquisition & Culture, based … [Read more…]